FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up

The FDA has extended emergency use authorization for Pfizer's COVID-19 booster to include 16 and 17-year-olds, following a study showing increased protection against the Omicron variant. Despite this, only 25% of the eligible U.S. population has received a booster. Experts emphasize the importance of boosters and masks, particularly N95s, in combating the variant. The World Health Organization warns Omicron could alter the pandemic's trajectory, and experts call for redefining 'fully vaccinated' to mean three doses.

What concerns are growing regarding the Omicron variant?

Evaluate responses using AI:

OFF

What recent change did the FDA make regarding booster shots for teenagers?

Evaluate responses using AI:

OFF

What did the Pfizer study indicate about booster shots?

Evaluate responses using AI:

OFF

What is the significance of the 25% figure mentioned in relation to booster shots?

Evaluate responses using AI:

OFF

What recommendations did health experts make regarding mask usage?

Evaluate responses using AI:

OFF